Stock data

訊映 (4155)

訊映 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$217.01M, up 60.0% from a year earlier. EPS over the last four quarters totals NT$1.72.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 訊映 in Insightr